Validation of Lipophosphonoxin-loaded Polycaprolactone Nanofiber Dressing for Full-thickness Wounds in a Porcine Model

This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m...

Full description

Saved in:
Bibliographic Details
Published inIn vivo (Athens) Vol. 39; no. 3; pp. 1331 - 1340
Main Authors ŠUCA, HUBERT, JUHÁS, ŠTEFAN, JUHÁSOVÁ, JANA, JENČOVÁ, VĚRA, KOŠŤÁKOVÁ, EVA KUŽELOVÁ, LUKÁŠ, DAVID, BOHUŠ, PETER, BALLOVÁ, ZUZANA, ZAJÍČEK, ROBERT, REJMAN, DOMINIK, GÁL, PETER
Format Journal Article
LanguageEnglish
Published Greece International Institute of Anticancer Research 01.05.2025
Subjects
Online AccessGet full text
ISSN0258-851X
1791-7549
1791-7549
DOI10.21873/invivo.13937

Cover

Abstract This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m ) on wound-healing outcomes and validate findings from previous murine studies. Full-thickness wounds were created on porcine skin and treated with the NANO-LPPO dressings of differing thickness. Positive control (Aquacel Ag+) and standard control (Jelonet) groups were included for comparison. Wound-healing progression was evaluated macroscopically and on the histological level. Macroscopic observations indicated no signs of infection in any group, with wounds covered by scabs by day 14. Thicker dressings (areal weights of 30 and 20 g/m ) demonstrated superior performance in promoting the formation of granulation tissue and healing compared to the thinner version (areal weight of 10 g/m ). LPPO-loading enhanced scaffold wettability and biodegradability without impairing healing outcomes. Both control groups exhibited similar healing characteristics. The findings underscore the importance of optimizing dressing thickness for effective wound healing. NANO-LPPO dressings exhibit translational potential as a therapeutic option for full-thickness wounds, warranting further preclinical and regulatory evaluation to support clinical application.
AbstractList This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m2) on wound-healing outcomes and validate findings from previous murine studies.BACKGROUND/AIMThis study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m2) on wound-healing outcomes and validate findings from previous murine studies.Full-thickness wounds were created on porcine skin and treated with the NANO-LPPO dressings of differing thickness. Positive control (Aquacel Ag+) and standard control (Jelonet) groups were included for comparison. Wound-healing progression was evaluated macroscopically and on the histological level.MATERIALS AND METHODSFull-thickness wounds were created on porcine skin and treated with the NANO-LPPO dressings of differing thickness. Positive control (Aquacel Ag+) and standard control (Jelonet) groups were included for comparison. Wound-healing progression was evaluated macroscopically and on the histological level.Macroscopic observations indicated no signs of infection in any group, with wounds covered by scabs by day 14. Thicker dressings (areal weights of 30 and 20 g/m2) demonstrated superior performance in promoting the formation of granulation tissue and healing compared to the thinner version (areal weight of 10 g/m2). LPPO-loading enhanced scaffold wettability and biodegradability without impairing healing outcomes. Both control groups exhibited similar healing characteristics.RESULTSMacroscopic observations indicated no signs of infection in any group, with wounds covered by scabs by day 14. Thicker dressings (areal weights of 30 and 20 g/m2) demonstrated superior performance in promoting the formation of granulation tissue and healing compared to the thinner version (areal weight of 10 g/m2). LPPO-loading enhanced scaffold wettability and biodegradability without impairing healing outcomes. Both control groups exhibited similar healing characteristics.The findings underscore the importance of optimizing dressing thickness for effective wound healing. NANO-LPPO dressings exhibit translational potential as a therapeutic option for full-thickness wounds, warranting further preclinical and regulatory evaluation to support clinical application.CONCLUSIONThe findings underscore the importance of optimizing dressing thickness for effective wound healing. NANO-LPPO dressings exhibit translational potential as a therapeutic option for full-thickness wounds, warranting further preclinical and regulatory evaluation to support clinical application.
This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m ) on wound-healing outcomes and validate findings from previous murine studies. Full-thickness wounds were created on porcine skin and treated with the NANO-LPPO dressings of differing thickness. Positive control (Aquacel Ag+) and standard control (Jelonet) groups were included for comparison. Wound-healing progression was evaluated macroscopically and on the histological level. Macroscopic observations indicated no signs of infection in any group, with wounds covered by scabs by day 14. Thicker dressings (areal weights of 30 and 20 g/m ) demonstrated superior performance in promoting the formation of granulation tissue and healing compared to the thinner version (areal weight of 10 g/m ). LPPO-loading enhanced scaffold wettability and biodegradability without impairing healing outcomes. Both control groups exhibited similar healing characteristics. The findings underscore the importance of optimizing dressing thickness for effective wound healing. NANO-LPPO dressings exhibit translational potential as a therapeutic option for full-thickness wounds, warranting further preclinical and regulatory evaluation to support clinical application.
Background/Aim: This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m2) on wound-healing outcomes and validate findings from previous murine studies.Materials and Methods: Full-thickness wounds were created on porcine skin and treated with the NANO-LPPO dressings of differing thickness. Positive control (Aquacel Ag+) and standard control (Jelonet) groups were included for comparison. Wound-healing progression was evaluated macroscopically and on the histological level.Results: Macroscopic observations indicated no signs of infection in any group, with wounds covered by scabs by day 14. Thicker dressings (areal weights of 30 and 20 g/m2) demonstrated superior performance in promoting the formation of granulation tissue and healing compared to the thinner version (areal weight of 10 g/m2). LPPO-loading enhanced scaffold wettability and biodegradability without impairing healing outcomes. Both control groups exhibited similar healing characteristics.Conclusion: The findings underscore the importance of optimizing dressing thickness for effective wound healing. NANO-LPPO dressings exhibit translational potential as a therapeutic option for full-thickness wounds, warranting further preclinical and regulatory evaluation to support clinical application.
Author KOŠŤÁKOVÁ, EVA KUŽELOVÁ
BOHUŠ, PETER
GÁL, PETER
JENČOVÁ, VĚRA
JUHÁS, ŠTEFAN
JUHÁSOVÁ, JANA
BALLOVÁ, ZUZANA
ZAJÍČEK, ROBERT
ŠUCA, HUBERT
REJMAN, DOMINIK
LUKÁŠ, DAVID
Author_xml – sequence: 1
  givenname: HUBERT
  surname: ŠUCA
  fullname: ŠUCA, HUBERT
– sequence: 2
  givenname: ŠTEFAN
  surname: JUHÁS
  fullname: JUHÁS, ŠTEFAN
– sequence: 3
  givenname: JANA
  surname: JUHÁSOVÁ
  fullname: JUHÁSOVÁ, JANA
– sequence: 4
  givenname: VĚRA
  surname: JENČOVÁ
  fullname: JENČOVÁ, VĚRA
– sequence: 5
  givenname: EVA KUŽELOVÁ
  surname: KOŠŤÁKOVÁ
  fullname: KOŠŤÁKOVÁ, EVA KUŽELOVÁ
– sequence: 6
  givenname: DAVID
  surname: LUKÁŠ
  fullname: LUKÁŠ, DAVID
– sequence: 7
  givenname: PETER
  surname: BOHUŠ
  fullname: BOHUŠ, PETER
– sequence: 8
  givenname: ZUZANA
  surname: BALLOVÁ
  fullname: BALLOVÁ, ZUZANA
– sequence: 9
  givenname: ROBERT
  surname: ZAJÍČEK
  fullname: ZAJÍČEK, ROBERT
– sequence: 10
  givenname: DOMINIK
  surname: REJMAN
  fullname: REJMAN, DOMINIK
– sequence: 11
  givenname: PETER
  surname: GÁL
  fullname: GÁL, PETER
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40294986$$D View this record in MEDLINE/PubMed
BookMark eNqFkc9vFCEcxYmpsdvq0ash8eJltjAwA5yMqbY22aoHf90IwzBdKst3hJmt-99LulWrFw-EhO97L5_v4wgdRIgOoaeULGsqBTvxceu3sKRMMfEALahQtBINVwdoQepGVrKhXw_RUc7XhLSCkPoROuSkVlzJdoG2n03wvZk8RAwDXvkRxjXkciL88LEKYHrX4w8QdtaMCYKxUwHA70yEwXcu4dfJ5ezjFR4g4bM5hGpae_stllf8BebYZ-wjNiUiWV-cl9C78Bg9HEzI7sndfYw-nb35ePq2Wr0_vzh9taosE3yquoJL1cBYQwdlrGytEM5aYzm3fdnGDYxzWXahNWm5aSSTrGs5V6q2dScadoyW-9w5jmZ3Y0LQY_Ibk3aaEn1boN4XqG8LLIaXe8M4dxvXWxenZP6YwHj99yT6tb6CrS4EvCaUloQXdwkJvs8uT3rjs3UhmOhgzppR1bZEFuwiff6P9BrmFEshmtWM8FZK2hbVs_tIv1l-fWIRVHuBTZBzcsN_dvwJQcCxTw
ContentType Journal Article
Copyright Copyright © 2025, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
2025. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2025 The Author(s). Published by the International Institute of Anticancer Research. 2025
Copyright_xml – notice: Copyright © 2025, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
– notice: 2025. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2025 The Author(s). Published by the International Institute of Anticancer Research. 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
DOI 10.21873/invivo.13937
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1791-7549
EndPage 1340
ExternalDocumentID 10.21873/invivo.13937
PMC12042011
40294986
10_21873_invivo_13937
Genre Journal Article
GeographicLocations Czech Republic
United Kingdom--UK
Germany
Prague Czech Republic
GeographicLocations_xml – name: Czech Republic
– name: Germany
– name: United Kingdom--UK
– name: Prague Czech Republic
GroupedDBID ---
53G
5GY
5VS
7RV
88E
8FI
8FJ
AAYXX
AENEX
AFKRA
ALMA_UNASSIGNED_HOLDINGS
CCPQU
CITATION
DIK
EBS
EJD
EMOBN
F5P
H13
HMCUK
HYE
KQ8
NAPCQ
OK1
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PSQYO
RHI
RPM
UKHRP
VRB
W8F
AFOSN
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FK
ABUWG
BENPR
FYUFA
K9.
M1P
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c374t-b00219f3351f9ac86c77eccac44cd067ef344829412064a58383b644992c2b753
IEDL.DBID 7X7
ISSN 0258-851X
1791-7549
IngestDate Tue Aug 19 23:23:23 EDT 2025
Thu Aug 21 18:26:12 EDT 2025
Fri Sep 05 17:22:26 EDT 2025
Sat Aug 23 13:35:32 EDT 2025
Fri May 16 02:46:58 EDT 2025
Wed Oct 01 05:28:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords repair
Wound healing
active wound dressing
regeneration
wound treatment
skin
antibacterial agent
Language English
License Copyright © 2025, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license
cc-by-nc-nd
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c374t-b00219f3351f9ac86c77eccac44cd067ef344829412064a58383b644992c2b753
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC12042011
PMID 40294986
PQID 3230468816
PQPubID 7212310
PageCount 10
ParticipantIDs unpaywall_primary_10_21873_invivo_13937
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12042011
proquest_miscellaneous_3196608482
proquest_journals_3230468816
pubmed_primary_40294986
crossref_primary_10_21873_invivo_13937
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-05-01
PublicationDateYYYYMMDD 2025-05-01
PublicationDate_xml – month: 05
  year: 2025
  text: 2025-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Greece
PublicationPlace_xml – name: Greece
– name: Highlands
PublicationTitle In vivo (Athens)
PublicationTitleAlternate In Vivo
PublicationYear 2025
Publisher International Institute of Anticancer Research
Publisher_xml – name: International Institute of Anticancer Research
SSID ssj0067002
Score 2.3917716
Snippet This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings...
Background/Aim: This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1331
SubjectTerms Animals
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - pharmacology
Bacterial infections
Bandages
Biocompatibility
Biodegradation
Collagen
Disease Models, Animal
Ethanol
Experiments
Histology
Infections
Lipoxins - administration & dosage
Lipoxins - chemistry
Lipoxins - pharmacology
Nanofibers - chemistry
Physiology
Polyesters - chemistry
Skin - drug effects
Skin - pathology
Swine
Wound healing
Wound Healing - drug effects
Title Validation of Lipophosphonoxin-loaded Polycaprolactone Nanofiber Dressing for Full-thickness Wounds in a Porcine Model
URI https://www.ncbi.nlm.nih.gov/pubmed/40294986
https://www.proquest.com/docview/3230468816
https://www.proquest.com/docview/3196608482
https://pubmed.ncbi.nlm.nih.gov/PMC12042011
https://iv.iiarjournals.org/content/invivo/39/3/1331.full.pdf
UnpaywallVersion publishedVersion
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1791-7549
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0067002
  issn: 1791-7549
  databaseCode: KQ8
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1791-7549
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0067002
  issn: 1791-7549
  databaseCode: RPM
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaglaAXxJtAWRkJwcl0EzuJfUI8WlUIqgpR2FvkOA6NiOx0X9B_z4yTDawq9RjlZftzPN94JvMR8nJa55JX05oZUwsGFkIwKYRgSmiruOC8LEO2xUl2fCY-zdLZsOG2GNIqN2tiWKgrb3CP_IDj7mUmZZy97S4YqkZhdHWQ0LhJdmOgKjir89nocOEfKCGKkKSSAbOY9TU2wajl_KBx62bt38RYEG7bJl0hmlfzJW-vXKcvf-u2_c8YHd0ldwYWSd_1sN8jN6y7T259GeLkD8j6O9DrXi2J-pp-bjrfnfsF5qH7P41jrdeVreipby-Nhpa0qLrjLIW1FiZbaef0Y8iPdT8pkFqKfirDxPhfuDDSHyjFtKCNoxoeMcdXUtRUax-Ss6PDbx-O2aCwwAzPxZIFE69qztO4VtrIzOQ5YmqEMBWMn605uG-JEnEC1EVjiJWXwKCUSkxSgqfziOw4aN4TQnOdVtlU2TxLBarWaalrOAS6qaaV5DwirzZjXHR9IY0CHJAARtGDUQQwIrK_QaAYvqdF8Q_9iLwYT8OXgOEN7axfwTUxVhqV0N6IPO4BG98EXrISSsLdcgvK8QKssr19xjXnodo2dF0gS4rI6xH163vw9PoePCN7CYoIh6zJfbKznK_sc2A2y3ISpu-E7L4_PDn9OglbT38BU6D8gA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlEuiDcpBYzE42S6iZ3EPiCEKNWWbisOLewtdRyHRkROuq-yf4rfyEyyCawq9dZjlJedGc9845nMR8jrQR5Lng1yZkwuGHgIwaQQgimhreKC8zRtqi2Oo-Gp-DoOxxvkT_cvDJZVdjaxMdRZZXCPfJfj7mUkpR99rC8YskZhdrWj0GjV4tAuLyFkm3442AP5vgmC_S8nn4dsxSrADI_FjDVuTeWch36utJGRiWOchxHCZGC7bc4hZAmU8ANw1xrTijwF1KBUYII0RpYIMPm3BAwHe_XH4z7Awz9emqxFEEoGSGbc9vQEJxrz3cItikX13scGdOs-8AqwvVqfuTV3tV5e6rL8z_nt3yN3V6iVfmrV7D7ZsO4BuX20yss_JIvvAOdbdiZa5XRU1FV9Xk2x7r36XThWVjqzGf1WlUujYSQlsvw4S8G2g3KndkL3mnpc95MCiKYYFzMsxP-Fhpj-QOqnKS0c1fCICb6SIodb-Yic3si3f0w2HQzvKaGxDrNooGwchQJZ8rTUORwCvFWDTHLukbfdN07qtnFHAgFPI4ykFUbSCMMjO50EktX6nSb_tM0jr_rTsPIwnaKdreZwjY-dTSWM1yNPWoH1b4KoXAkl4W65Jsr-AuzqvX7GFedNd2-YukBU5pF3vdSvn8H29TN4SbaGJ0ejZHRwfPiM3AmQwLip2Nwhm7PJ3D4HVDVLXzSqTMnZTa-dvwPRNLU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validation+of+Lipophosphonoxin-loaded+Polycaprolactone+Nanofiber+Dressing+for+Full-thickness+Wounds+in+a+Porcine+Model&rft.jtitle=In+vivo+%28Athens%29&rft.au=%C5%A0uca%2C+Hubert&rft.au=Juh%C3%A1s%2C+%C5%A0tefan&rft.au=Juh%C3%A1sov%C3%A1%2C+Jana&rft.au=Jen%C4%8Dov%C3%A1%2C+V%C4%9Bra&rft.date=2025-05-01&rft.issn=1791-7549&rft.eissn=1791-7549&rft.volume=39&rft.issue=3&rft.spage=1331&rft_id=info:doi/10.21873%2Finvivo.13937&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0258-851X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0258-851X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0258-851X&client=summon